Results 1 to 10 of about 43,468 (306)

Serum Alpha and Beta‐CGRP Levels in Chronic Migraine Patients Before and After Monoclonal Antibodies Against CGRP or its Receptor [PDF]

open access: greenAnnals of Neurology, 2023
The objective of this study was to analyze the evolution of alpha and beta‐CGRP circulating levels throughout CGRP monoclonal antibodies (mAbs) treatment in patients with chronic migraine (CM).
Gabriel Gárate   +6 more
openalex   +2 more sources

Evaluation of mRNA Expression of Calcitonin Gene-Dependent Peptide (CGRP) and Rat Calcitonin (rCT) in the Periaqueductal Gray Area (PAG) of Diabetic Rats in the Formalin Test [PDF]

open access: diamondMajallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Īlām, 2022
Introduction: CGRP and rCT are involved in descending pain control areas. This study aimed to evaluate the effect of intracerebroventricular administration (ICV) of CGRP and rCT on mRNA expression of CGRP and rCT peptides in the Periaqueductal Gray Area (
Olya Moshiri   +4 more
doaj   +2 more sources

A novel bioactive peptide-peptoid hybrid of alpha-calcitonin gene-related peptide protects against pressure-overload induced heart failure [PDF]

open access: yesFrontiers in Pharmacology
BackgroundAlpha-calcitonin gene-related peptide (α-CGRP) is a cardioprotective neuropeptide. However, due to low bioavailability, its use as a therapeutic agent is limited.
Ambrish Kumar   +4 more
doaj   +2 more sources

Tear fluid CGRP rises during glyceryl trinitrate-induced headache in migraine patients [PDF]

open access: yesThe Journal of Headache and Pain
Background Calcitonin gene-related peptide (CGRP) plays an important role in migraine pathophysiology and is a marker of trigeminal activity. We investigated tear fluid CGRP levels interictally and ictally using the glyceryl trinitrate (GTN) experimental
Katharina Kamm   +3 more
doaj   +2 more sources

C-fibers may modulate adjacent Aδ-fibers through axon-axon CGRP signaling at nodes of Ranvier in the trigeminal system

open access: yesThe Journal of Headache and Pain, 2019
Background Monoclonal antibodies (mAbs) towards CGRP or the CGRP receptor show good prophylactic antimigraine efficacy. However, their site of action is still elusive.
Jacob C. A. Edvinsson   +6 more
doaj   +2 more sources

CGRP physiology, pharmacology, and therapeutic targets: Migraine and beyond.

open access: yesPhysiological Reviews, 2022
Calcitonin gene-related peptide (CGRP) is a neuropeptide with diverse physiological functions. Its two isoforms (α and β) are widely expressed throughout the body in sensory neurons, as well as in other cell types, such as motor neurons and ...
A. Russo, D. Hay
semanticscholar   +1 more source

Shared and independent roles of CGRP and PACAP in migraine pathophysiology

open access: yesThe Journal of Headache and Pain, 2023
The neuropeptides calcitonin gene-related peptide (CGRP) and pituitary adenylate cyclase-activating polypeptide (PACAP) have emerged as mediators of migraine pathogenesis.
Adisa Kuburas, A. Russo
semanticscholar   +1 more source

A Scoping Review and Meta-Analysis of Anti-CGRP Monoclonal Antibodies: Predicting Response

open access: yesPharmaceuticals, 2023
Calcitonin gene-related peptide-targeted monoclonal antibodies (CGRP mAbs) are increasingly being used as preventive treatments for migraine. Their effectiveness and safety were established through numerous randomized placebo-controlled trials and real ...
Jaehwa Hong   +5 more
semanticscholar   +1 more source

Schwann cell endosome CGRP signals elicit periorbital mechanical allodynia in mice

open access: yesNature Communications, 2022
Efficacy of monoclonal antibodies against calcitonin gene-related peptide (CGRP) or its receptor (calcitonin receptor-like receptor/receptor activity modifying protein-1, CLR/RAMP1) implicates peripherally-released CGRP in migraine pain.
Francesco De Logu   +18 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy